Singapore-Developed Device Aims to Improve Seniors' Muscle Strength

Singapore General Hospital (SGH) is advocating for increased access to QMT, a device developed locally and approved by regulatory authorities in Singapore and the US for medical applications. The precursor to QMT, known as Bixeps, is also available.

The QMT and Bixeps devices are designed to safely and non-invasively improve muscle strength, increase mobility, and alleviate pain. The initiative aims to help seniors maintain their muscle mass, which could significantly reduce the incidence of falls and fractures, common issues within an aging demographic.

Research in Singapore indicates that between 13% and 25% of seniors suffer from sarcopenia, an age-related decline in muscle mass and strength. This condition not only leads to weakness but also impairs balance, consequently increasing the risk of falls, hospitalization, and a diminished quality of life.

According to the national health portal HealthHub, approximately one-third of individuals aged 60 and above experience one or more falls annually. These falls can result in various complications, including fractures, particularly hip fractures, which often necessitate prolonged hospital stays and rehabilitation.

Singapore's Minister for Health, Ong Ye Kung, has previously highlighted an increase in average hospital stays, partly attributed to older patients with more complex medical conditions. He has also warned of a projected significant rise in osteoporotic fractures in Singapore by 2035.

Enhancing access to QMT and Bixeps is seen as contributing to Singapore's broader strategies for promoting active aging. Government initiatives, including active aging centers and the "Age Strong" program, are in place to bolster the physical, nutritional, and mental well-being of the nation's elderly population.